NCT06209268View on ClinicalTrials.gov

The Impact of Selective Vitamin D Receptor Activation on Clinical Outcomes in Septic Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

October 1, 2025

Study Completion Date

February 1, 2026

Conditions
Sepsis
Interventions
DRUG

Paricalcitol injection

5 μg intravenous paricalcitol (1 mL) per day in five consecutive days

DRUG

Placebo

0.9% NaCl 1 ml per day in five consecutive days

All Listed Sponsors
lead

University of Split, School of Medicine

OTHER

NCT06209268 - The Impact of Selective Vitamin D Receptor Activation on Clinical Outcomes in Septic Patients | Biotech Hunter | Biotech Hunter